Back to Online Symposia Home Page
|
|
Program Description
The primary goal of this educational initiative is to provide clinicians with the most up-to-date information regarding fibromyalgia, with a focus on effective diagnostic criteria and management strategies that help optimize functional ability and quality of life for affected persons.
Learning Objectives
By participating in this activity, you will be able to:
- Explain the importance of understanding the pathophysiology and identifying the nonspecific symptoms in the detection and diagnosis of fibromyalgia syndrome
- Understand the quality-of-life implications of fibromyalgia syndrome
- Evaluate the efficacy and safety of nonpharmacologic and pharmacologic treatments for the management of fibromyalgia syndrome
Who Will Benefit
This activity was designed to meet the continuing education needs of psychiatrists and other physicians, physician assistants, registered nurses, psychiatric nurses and advanced practice nurses. Other mental health professionals may find this activity informative and should check with their state licensing and certification boards to determine if it meets their continuing education requirements.
Your Distinguished Faculty
Fibromyalgia: Pathophysiology, Diagnostic Challenges and Quality-of-Life Implications
Don L. Goldenberg, MD
Chief of Rheumatology, Newton-Wellesley Hospital
Professor of Medicine, Tufts University School of Medicine
Director, Arthritis-Fibromyalgia Center of Newton-Wellesley Hospital
Faculty Disclosures
Don L. Goldenberg, MD, is on the Speakers Bureau for Pfizer Inc. and Merck & Co., Inc. He also serves as a consultant for Pfizer Inc., Forest Pharmaceuticals, Inc., and Eli Lilly and Company.
Management of Fibromyalgia: Efficacy and Safety of Nonpharmacologic and Pharmacologic Interventions
Rakesh Jain, MD, MPH
Director of Psychopharmacology Research, University of Texas Medical School, Houston
Director of Psychiatric Drug Research for R/D Clinical Research, Lake Jackson, Texas
Faculty Disclosures
Rakesh Jain, MD, MPH, is a member of the Speakers Bureau for, and receives honoraria and grants/research support from, Eli Lilly and Company and GlaxoSmithKline. He serves as a consultant for Eli Lilly and Company, Roche Laboratories Inc., Shire Pharmaceuticals Inc., and Takeda Pharmaceuticals America, Inc. He also is a member of the Speakers Bureau for Roche Laboratories and Shire Pharmaceuticals Inc., receives grants/research support from Abbott and Merck & Co., Inc., and receives honoraria from Shire Pharmaceuticals Inc.
|
Commercial Support
Supported by an educational grant from Eli Lilly and Company
Disclaimers
The content of this video activity may include product information that is inconsistent with or outside of the approved labeling for these products in the United States. Before prescribing any medication, you must familiarize yourself with the manufacturer's product information.
To earn continuing education credit, view this online course and complete the posttest and evaluation provided. A passing score of 70% or more must be achieved on the posttest. A link is provided within this online activity to access the posttest and evaluation. You will have the option of printing a Statement of Credit for your records after submission of the evaluation.
CME LLC and Eli Lilly and Company are not responsible for the speaker's statements, materials, acts or omissions. |
|
Continuing Medical Education
CME LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
CME LLC designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
CME credits from activities presented by ACCME accredited providers may be used toward American Osteopathic Association (AOA) Category 2-A requirements.
The American Academy of Physician Assistants (AAPA) accepts AMA PRA Category 1 Credit(s)™ from organizations accredited by the ACCME.
CME LLC is approved by the California Board of Registered Nursing, Provider No. CEP12748, and designates this educational activity for 1.0 contact hour for nurses.
The American Nurses Credentialing Center (ANCC) accepts AMA PRA Category 1 Credit(s)™ toward recertification requirements.
Content Originally Presented: October 13, 2007
Online Date: December 20, 2007
Credit Expiration Date: December 19, 2008
This activity is based on the symposium Alleviating the Burden of Fibromyalgia: A Psychiatrist's Approach at the 20th Annual U.S Psychiatric and Mental Health Congress in October, 2007 in Orlando, Fla. Participants who attended the live symposium mentioned above cannot claim credit for this activity.
|
